These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
329 related articles for article (PubMed ID: 9751635)
1. Interleukin 4 inhibits growth and induces apoptosis in human breast cancer cells. Gooch JL; Lee AV; Yee D Cancer Res; 1998 Sep; 58(18):4199-205. PubMed ID: 9751635 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of colon and breast carcinoma cell growth by interleukin-4. Toi M; Bicknell R; Harris AL Cancer Res; 1992 Jan; 52(2):275-9. PubMed ID: 1728401 [TBL] [Abstract][Full Text] [Related]
3. Growth inhibition of human breast cancer cells in vitro with an antibody against the type I somatomedin receptor. Arteaga CL; Osborne CK Cancer Res; 1989 Nov; 49(22):6237-41. PubMed ID: 2553250 [TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factors modulate the growth inhibitory effects of retinoic acid on MCF-7 breast cancer cells. Bentel JM; Lebwohl DE; Cullen KJ; Rubin MS; Rosen N; Mendelsohn J; Miller WH J Cell Physiol; 1995 Oct; 165(1):212-21. PubMed ID: 7559803 [TBL] [Abstract][Full Text] [Related]
5. Growth factors and chemotherapeutic modulation of breast cancer cells. Ciftci K; Su J; Trovitch PB J Pharm Pharmacol; 2003 Aug; 55(8):1135-41. PubMed ID: 12956904 [TBL] [Abstract][Full Text] [Related]
6. Interleukin-1 alpha and interleukin-6 act additively to inhibit growth of MCF-7 breast cancer cells in vitro. Danforth DN; Sgagias MK Cancer Res; 1993 Apr; 53(7):1538-45. PubMed ID: 8453620 [TBL] [Abstract][Full Text] [Related]
7. Recombinant insulin-like growth factor binding protein-1 inhibits IGF-I, serum, and estrogen-dependent growth of MCF-7 human breast cancer cells. Figueroa JA; Sharma J; Jackson JG; McDermott MJ; Hilsenbeck SG; Yee D J Cell Physiol; 1993 Nov; 157(2):229-36. PubMed ID: 7693722 [TBL] [Abstract][Full Text] [Related]
8. Retinoic acid induces expression of the interleukin-1beta gene in cultured normal human mammary epithelial cells and in human breast carcinoma lines. Liu L; Gudas LJ J Cell Physiol; 2002 Nov; 193(2):244-52. PubMed ID: 12385002 [TBL] [Abstract][Full Text] [Related]
9. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I. Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306 [TBL] [Abstract][Full Text] [Related]
10. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta. Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749 [TBL] [Abstract][Full Text] [Related]
11. 3,3'-diindolylmethane and paclitaxel act synergistically to promote apoptosis in HER2/Neu human breast cancer cells. McGuire KP; Ngoubilly N; Neavyn M; Lanza-Jacoby S J Surg Res; 2006 May; 132(2):208-13. PubMed ID: 16580691 [TBL] [Abstract][Full Text] [Related]
12. [The inhibiting effect of genistein on the growth of human breast cancer cells in vitro]. He FJ; Wang J; Niu JZ; Wang JF Zhongguo Zhong Yao Za Zhi; 2002 Dec; 27(12):936-9. PubMed ID: 12776537 [TBL] [Abstract][Full Text] [Related]
13. Osteoblast-derived growth factors enhance adriamycin-cytostasis of MCF-7 human breast cancer cells. Choki I; Sourla A; Reyes-Moreno C; Koutsilieris M Anticancer Res; 1998; 18(6A):4213-24. PubMed ID: 9891470 [TBL] [Abstract][Full Text] [Related]
14. Tanshinone I effectively induces apoptosis in estrogen receptor-positive (MCF-7) and estrogen receptor-negative (MDA-MB-231) breast cancer cells. Nizamutdinova IT; Lee GW; Son KH; Jeon SJ; Kang SS; Kim YS; Lee JH; Seo HG; Chang KC; Kim HJ Int J Oncol; 2008 Sep; 33(3):485-91. PubMed ID: 18695877 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of human breast cancer cell proliferation in tissue culture by the neuroleptic agents pimozide and thioridazine. Strobl JS; Kirkwood KL; Lantz TK; Lewine MA; Peterson VA; Worley JF Cancer Res; 1990 Sep; 50(17):5399-405. PubMed ID: 2386945 [TBL] [Abstract][Full Text] [Related]
16. Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis. Afonja O; Juste D; Das S; Matsuhashi S; Samuels HH Oncogene; 2004 Oct; 23(49):8135-45. PubMed ID: 15361828 [TBL] [Abstract][Full Text] [Related]
17. A dominant negative mutant of the insulin-like growth factor-I receptor inhibits the adhesion, invasion, and metastasis of breast cancer. Dunn SE; Ehrlich M; Sharp NJ; Reiss K; Solomon G; Hawkins R; Baserga R; Barrett JC Cancer Res; 1998 Aug; 58(15):3353-61. PubMed ID: 9699666 [TBL] [Abstract][Full Text] [Related]
18. The effect of droloxifene on the insulin-like growth factor-I-stimulated growth of breast cancer cells. Kawamura I; Lacey E; Mizota T; Tsujimoto S; Nishigaki F; Manda T; Shimomura K Anticancer Res; 1994; 14(2A):427-31. PubMed ID: 8017842 [TBL] [Abstract][Full Text] [Related]
19. Role of estrogen-induced insulin-like growth factors in the proliferation of human breast cancer cells. van der Burg B; Isbrücker L; van Selm-Miltenburg AJ; de Laat SW; van Zoelen EJ Cancer Res; 1990 Dec; 50(24):7770-4. PubMed ID: 2174732 [TBL] [Abstract][Full Text] [Related]
20. Re-expression of estrogen receptor alpha in estrogen receptor alpha-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling and growth. Oesterreich S; Zhang P; Guler RL; Sun X; Curran EM; Welshons WV; Osborne CK; Lee AV Cancer Res; 2001 Aug; 61(15):5771-7. PubMed ID: 11479214 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]